Abingworth's latest fund raises $315 mln
Abingworth said July 9 that it closed its latest fund at $315 million. Abingworth Bioventures VII exceeded its target of $300 million and is Abingworth’s 12th fund to invest in life sciences companies in Europe and the US.
9 July 2018•2 mins read
